19
Total investments
2
Early stage
10
Mid stage
5
Late stage
8y
Years active
Portfolio
19 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Nov 2024
Auxeris connects businesses with the best independent recruiters in the industry. Our focus on innovation and technology sets us apart from traditional recruitment services by streamlining the process and reducing the administrative burden for both businesses and recruiters. From data management to contracts, invoicing, and payments, we have taken care of every aspect to reduce unnecessary admin.
Our network of highly skilled and experienced recruiters bring a unique combination of industry knowledge and recruitment expertise to ensure that your company finds the best match for your open positions. Our recruiters are dedicated to providing a personalised service and ensuring that your requirements are met. With our technology, they are able to focus on what they do best: finding top talent for your business.
Get in touch if you are looking for help with temp, temp to perm and permanent recruitment solutions.
Angel Investor
Feb 2024
Ori is building the AI backbone for the future, enabling teams to advance groundbreaking technology. We believe the true potential of AI will be unlocked by how seamlessly teams can access and deploy the infrastructure they need to train, serve, and scale models.
As a trusted partner, Ori provides end-to-end AI infrastructure—combining powerful GPU compute with a flexible software layer that optimizes resources.
With Ori, teams can explore, build, and scale AI innovations effortlessly, transforming how software and hardware work together to drive the next wave of AI breakthroughs.
Angel Investor
Mar 2023
4M Therapeutics Inc. (4MTx) is developing targeted therapies for central nervous system (CNS) disorders. Our discovery platform was developed at Harvard, MIT and the University of Washington to uncover how drugs like lithium enhance the health of living human brain cells – and then to design better alternatives.
Pre-clinical data show that our lead asset 4MT2001 has the potential to provide a better combination of efficacy and safety than lithium for the treatment of bipolar disorder (BPD). Clinical trials will begin in early 2025 as we seek to address a $6 billion US market. Beyond BPD, our pipeline has the potential to address Alzheimer’s disease, frontal temporal dementia, and other brain disorders with broad clinical, commercial, and partnering potential.
4MTx is led by CEO Pablo Lapuerta, who has developed and launched multiple drugs. He introduced into clinical trials the first targeted CNS kinase inhibitor to show successful proof-of-concept data. Board Chair Don Hayden was previously President of Global Pharmaceuticals at Bristol Myers-Squibb and led the development and commercialization of CNS blockbuster Abilify (peak annual sales > $6B). Board member Dr. Lawrence Goldstein co-founded publicly-traded Cytokinetics and is professor emeritus at UC San Diego with extensive CNS experience.
Angel Investor
Oct 2022
Form Energy is an American company driving innovation in energy technology and manufacturing. Our cost-effective, multi-day energy storage technology is designed to ensure a clean, secure, and reliable electric grid, even during prolonged periods of stress.
We are assembling a team of talented and driven individuals to work at our facilities in West Virginia, Pennsylvania, Massachusetts, and California. If you’re eager to make a meaningful impact through your work, while rapidly accelerating your career, take a look at our open roles!
Learn more and apply here: www.formenergy.com/careers
Private Investor
Aug 2022
Finix is a payment processor that makes it easy for software platforms, marketplaces, and individual businesses of all sizes to accept payments and send money while maximizing revenue and reducing costs.
Finix is trusted by startups and publicly traded companies alike to build and scale their payments infrastructure. Headquartered in San Francisco, Finix is a privately held company with funding from American Express Ventures, Bain Capital Ventures, Homebrew, Inspired Capital, Lightspeed Venture Partners, Sequoia Capital, Visa, and more.
Angel Investor
Jul 2022
Exostellar, Inc. is a next-generation cloud resource optimization and management platform that uses cutting-edge distributed container infrastructure as well as Artificial intelligence (AI) and Machine Learning (ML) to help enterprises reduce spending in the cloud by up to 80%, while enhancing both operational security and performance
We help enterprise companies achieve cloud optimizations and cost reductions without service interruptions.
- Lower costs by up to 80%
- No service interrupts, even for stateful applications
- Support legacy applications without any modifications
- Any cloud - AWS, google, Azure, VMWare, etc
- Works for Kubernetes and cloud-native application containers
- Reduce job completion time and improve customer experience
Private Investor
Apr 2022
Nestment helps first-time homebuyers navigate the homebuying process with confidence through 1:1 support, a trusted network of agents and lenders, practical education, and AI-powered tools.
Private Investor
Mar 2022
Optibus’ vision is to be the modern operating system for mass transportation.
Optibus is an end-to-end, cross-functional software platform for transportation planning, scheduling, rostering, and operations.
Founded in 2014, transportation agencies and operators in over 5,000 cities worldwide trust Optibus to increase efficiency and ridership, improve service quality, promote transportation equity, reduce emissions and costs, and modernize their operations. Our platform enables operators and agencies to plan and analyze better routes, schedules, rosters, and much more.
Optibus is a cloud-native solution powered by artificial intelligence (AI) and advanced optimization algorithms that are revolutionizing the transportation industry across the globe. Optibus has been recognized as a technology pioneer by the World Economic Forum for its role in transforming the transportation industry, promoting equity, sustainability, and smart cities. Learn more: www.optibus.com
Private Investor
Mar 2022
Have you ever thought of using AI and MLOps to make your training datasets ML-ready automatically? Thats what we do!
With the Alectio platform, youll never have to waste time or money on cleaning and preparing your dataset.
Alectio is the first DataPrepOps platform built for machine learning. We use Active Learning, Meta Learning, Machine Teaching and generative models to tune your raw training data in order to increase machine learning model performance while reducing model training cost.
To learn how you can put your Data Prep process on autopilot today, schedule a demo at alectio.com.
Private Investor
Mar 2022
Brightseed is a pioneer in biosciences and artificial intelligence (A.I.) that illuminates nature to restore human health. Brightseed’s proprietary A.I., Forager®, accelerates bioactive discovery, biological validation and ingredient formulation from years to months, rapidly revealing new connections between nature and humanity. Through Forager® and clinical evaluation, Brightseed partners with organizations across the consumer health continuum to offer insight into the world of bioactives and health solutions. Brightseed produces branded, proprietary, clinically proven bioactives that are sold to leading dietary supplement, food & beverage CPG, specialty nutrition and medical food companies for incorporation into health beneficial consumer products.
Visit www.brightseedbio.com to learn more.
Angel Investor
Feb 2022
Alto provides an easier, more efficient and more affordable pharmacy experience for patients, providers, and partners. Alto Pharmacy is America’s leading digitally-powered pharmacy, transforming a $500 billion industry. Our full-service, digitally-powered pharmacy makes it simpler for patients to live their healthiest life. Alto Technologies empowers partners with tailored solutions that elevate the patient experience, improve medication access and delivery, and set new industry standards for convenience, cost, and care. Alto combines expert pharmacist care with a technology-led platform to deliver a more convenient and affordable experience for those who need medication.
Private Investor
Feb 2022
Millions of people depend on their employee benefits for healthcare, financial protection, and support. Today, information travels in real-time, but it can still take months to enroll in benefits. Delays, errors, and gaps in coverage are all too common.
Noyo is the solution. As the first operating system for benefits, we’re pioneering a new category of technology that transforms how ben-admin companies can manage, exchange, and leverage enrollment data.
Our solutions eliminate costs and complexity while powering new possibilities for HR teams and employees.
Private Investor
Feb 2022
Paladins mission is to increase access to justice by helping legal teams run more efficient pro bono programs.
Investor
Dec 2021
Brex is the intelligent finance platform built for speed and control, empowering founders and finance teams to spend smarter and move faster globally with intuitive corporate cards, banking, expenses, and travel. Over 35,000 companies run on Brex, including DoorDash, ServiceTitan, Wiz, and Five Guys.
Private Investor
Dec 2021
Canela Media is a leading digital media tech company offering brands a complete ecosystem to connect with multicultural audiences leading with its free streaming service, Canela.TV, offering on-demand Latino-focused movies and TV entertainment through multiple platforms. Additionally, Canela Media reaches more than 20 million unique Hispanics across its 180+ premium Spanish-language sites and influencer database. Combined with the company’s proprietary data, Canela Media possesses in-depth knowledge and understanding of how to establish meaningful and culturally relevant connections with the new mainstream – U.S. Hispanics. Headquartered in New York, Canela Media is ranked as the fourth largest Hispanic ad-focused company and is female- and minority-owned.
Show all 19 investments ↓
Experience · 22 entries
All (22)
Investments (19)
2024
Angel Investor
Nov 2024
Auxeris connects businesses with the best independent recruiters in the industry. Our focus on innovation and technology sets us apart from traditional recruitment services by streamlining the process and reducing the administrative burden for both businesses and recruiters. From data management to contracts, invoicing, and payments, we have taken care of every aspect to reduce unnecessary admin.
Our network of highly skilled and experienced recruiters bring a unique combination of industry knowledge and recruitment expertise to ensure that your company finds the best match for your open positions. Our recruiters are dedicated to providing a personalised service and ensuring that your requirements are met. With our technology, they are able to focus on what they do best: finding top talent for your business.
Get in touch if you are looking for help with temp, temp to perm and permanent recruitment solutions.
Angel Investor
Feb 2024
Ori is building the AI backbone for the future, enabling teams to advance groundbreaking technology. We believe the true potential of AI will be unlocked by how seamlessly teams can access and deploy the infrastructure they need to train, serve, and scale models.
As a trusted partner, Ori provides end-to-end AI infrastructure—combining powerful GPU compute with a flexible software layer that optimizes resources.
With Ori, teams can explore, build, and scale AI innovations effortlessly, transforming how software and hardware work together to drive the next wave of AI breakthroughs.
2023
Angel Investor
Mar 2023
4M Therapeutics Inc. (4MTx) is developing targeted therapies for central nervous system (CNS) disorders. Our discovery platform was developed at Harvard, MIT and the University of Washington to uncover how drugs like lithium enhance the health of living human brain cells – and then to design better alternatives.
Pre-clinical data show that our lead asset 4MT2001 has the potential to provide a better combination of efficacy and safety than lithium for the treatment of bipolar disorder (BPD). Clinical trials will begin in early 2025 as we seek to address a $6 billion US market. Beyond BPD, our pipeline has the potential to address Alzheimer’s disease, frontal temporal dementia, and other brain disorders with broad clinical, commercial, and partnering potential.
4MTx is led by CEO Pablo Lapuerta, who has developed and launched multiple drugs. He introduced into clinical trials the first targeted CNS kinase inhibitor to show successful proof-of-concept data. Board Chair Don Hayden was previously President of Global Pharmaceuticals at Bristol Myers-Squibb and led the development and commercialization of CNS blockbuster Abilify (peak annual sales > $6B). Board member Dr. Lawrence Goldstein co-founded publicly-traded Cytokinetics and is professor emeritus at UC San Diego with extensive CNS experience.
2022
Angel Investor
Oct 2022
Form Energy is an American company driving innovation in energy technology and manufacturing. Our cost-effective, multi-day energy storage technology is designed to ensure a clean, secure, and reliable electric grid, even during prolonged periods of stress.
We are assembling a team of talented and driven individuals to work at our facilities in West Virginia, Pennsylvania, Massachusetts, and California. If you’re eager to make a meaningful impact through your work, while rapidly accelerating your career, take a look at our open roles!
Learn more and apply here: www.formenergy.com/careers
Private Investor
Aug 2022
Finix is a payment processor that makes it easy for software platforms, marketplaces, and individual businesses of all sizes to accept payments and send money while maximizing revenue and reducing costs.
Finix is trusted by startups and publicly traded companies alike to build and scale their payments infrastructure. Headquartered in San Francisco, Finix is a privately held company with funding from American Express Ventures, Bain Capital Ventures, Homebrew, Inspired Capital, Lightspeed Venture Partners, Sequoia Capital, Visa, and more.
Show all 22 entries ↓
Investment activity
2018–2024 · 19 investments
Recent (last 2 years)Earlier
